Kenvue rises in early trading, reversing some of yesterday's drop, as scientists push back on Tylenol-autism link
Shares slumped to a record low yesterday, as President Trump suggested a connection between the drug and higher autism rates.
http://dlvr.it/TNF3c2
http://dlvr.it/TNF3c2
